AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca dividends declared per Ordinary Share ($) ($)
Consolidated Income Statement (Postgres DB)
Latest, FY2025
3.13
Period ended Dec 31, 2025
Change on a year earlier
+5.4%
2.97 in FY2024
History
6 years
Since FY2020
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Dividends declared per Ordinary Share ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.13 | +5.4% | Form 20-F (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2.97 | +2.4% | Form 20-F (filed 2025-02-18) ↗ |
| FY2023 | Dec 31, 2023 | 2.90 | 0.0% | Form 20-F (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 2.90 | +3.6% | Form 20-F (filed 2023-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 2.80 | 0.0% | Form 20-F (filed 2023-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 2.80 | – | Form 20-F (filed 2023-02-21) ↗ |
Cite this data
StockData. (2026). AstraZeneca Dividends declared per Ordinary Share ($) ($), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_dps
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.